Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
J Neurosci ; 31(2): 453-60, 2011 Jan 12.
Article in English | MEDLINE | ID: mdl-21228155

ABSTRACT

The nucleolus represents an essential stress sensor for the cell. However, the molecular consequences of nucleolar damage and their possible link with neurodegenerative diseases remain to be elucidated. Here, we show that nucleolar damage is present in both genders in Parkinson's disease (PD) and in the pharmacological PD model induced by the neurotoxin 1,2,3,6-tetrahydro-1-methyl-4-phenylpyridine hydrochloride (MPTP). Mouse mutants with nucleolar disruption restricted to dopaminergic (DA) neurons show phenotypic alterations that resemble PD, such as progressive and differential loss of DA neurons and locomotor abnormalities. At the molecular level, nucleolar disruption results in increased p53 levels and downregulation of mammalian target of rapamycin (mTOR) activity, leading to mitochondrial dysfunction and increased oxidative stress, similar to PD. In turn, increased oxidative stress induced by MPTP causes mTOR and ribosomal RNA synthesis inhibition. Collectively, these observations suggest that the interplay between nucleolar dysfunction and increased oxidative stress, involving p53 and mTOR signaling, may constitute a destructive axis in experimental and sporadic PD.


Subject(s)
Cell Nucleolus/pathology , Dopamine/metabolism , Neurons/pathology , Oxidative Stress , Parkinsonian Disorders/metabolism , Parkinsonian Disorders/pathology , TOR Serine-Threonine Kinases/physiology , 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine , Animals , Brain/metabolism , Brain/pathology , Cell Nucleolus/metabolism , Gene Deletion , Humans , Mice , Mice, Inbred C57BL , Mice, Mutant Strains , Mice, Transgenic , Mitochondria/physiology , Motor Skills , Neurons/metabolism , Parkinson Disease/pathology , Parkinsonian Disorders/physiopathology , Pol1 Transcription Initiation Complex Proteins/genetics , Signal Transduction , Tumor Suppressor Protein p53/physiology
2.
Endocrinology ; 150(4): 1775-81, 2009 Apr.
Article in English | MEDLINE | ID: mdl-19036879

ABSTRACT

Glucocorticoid hormones (GCs) have been thought to determine the fate of chromaffin cells from sympathoadrenal progenitor cells. The analysis of mice carrying a germ line deletion of the glucocorticoid receptor (GR) gene has challenged these previous results because the embryonic development of adrenal chromaffin cells is largely unaltered. In the present study, we have analyzed the role of GC-dependent signaling in the postnatal development of adrenal chromaffin cells by conditional inactivation of the GR gene in cells expressing dopamine-beta-hydroxylase, an enzyme required for the synthesis of noradrenaline and adrenaline. These mutant mice are viable, allowing to study whether in the absence of GC signaling further development of the adrenal medulla is affected. Our analysis shows that the loss of GR leads not only to the loss of phenylethanolamine-N-methyl-transferase expression and, therefore, to inhibition of adrenaline synthesis, but also to a dramatic reduction in the number of adrenal chromaffin cells. We provide evidence that increased apoptotic cell death is the main consequence of GR loss. These findings define the essential role of GCs for survival of chromaffin cells and underscore the specific requirement of GCs for adrenergic chromaffin cell differentiation and maintenance.


Subject(s)
Cell Survival/genetics , Chromaffin Cells/cytology , Chromaffin Cells/metabolism , Dopamine beta-Hydroxylase/metabolism , Receptors, Glucocorticoid/genetics , Receptors, Glucocorticoid/physiology , Adrenal Glands/cytology , Adrenal Glands/metabolism , Adrenal Medulla/metabolism , Adrenal Medulla/pathology , Animals , Cells, Cultured , Immunohistochemistry , In Situ Nick-End Labeling , Mice , Phenylethanolamine N-Methyltransferase/metabolism
3.
J Neurosci ; 28(48): 12759-64, 2008 Nov 26.
Article in English | MEDLINE | ID: mdl-19036968

ABSTRACT

Transcription of rRNA genes is essential for maintaining nucleolar integrity, a hallmark for the healthy state and proliferation rate of a cell. Inhibition of rRNA synthesis leads to disintegration of the nucleolus, elevated levels of p53, and induction of cell suicide, identifying the nucleolus as a critical stress sensor. Whether deregulation of rRNA synthesis is causally involved in neurodegeneration by promoting cell death and/or by inhibiting cellular growth has however not been addressed. The transcription factor TIF-IA plays a central role in mammalian rRNA synthesis, regulating the transcriptional activity of RNA polymerase I. To investigate the consequences of nucleolar perturbation in the nervous system, we have chosen to specifically ablate the gene encoding the transcription factor TIF-IA in two different contexts: neural progenitors and hippocampal neurons. Here, we show that ablation of TIF-IA leads to impaired nucleolar activity and results in increased levels of the proapoptotic transcription factor p53 in both neural progenitors and hippocampal neurons but induces rapid apoptosis only in neural progenitors. Nondividing cells of the adult hippocampus are more refractory to loss of rRNA transcription and face a protracted degeneration. Our study provides an unexploited strategy to initiate neurodegeneration based on perturbation of nucleolar function and underscores a novel perspective to study the cellular and molecular changes involved in the neurodegenerative processes.


Subject(s)
Apoptosis/genetics , Hippocampus/metabolism , Nerve Degeneration/genetics , Neurons/metabolism , Pol1 Transcription Initiation Complex Proteins/physiology , RNA, Ribosomal/biosynthesis , Animals , Cell Nucleolus/genetics , Cell Nucleolus/metabolism , Cell Nucleolus/pathology , Hippocampus/pathology , Hippocampus/physiopathology , Mice , Mice, Knockout , Mice, Transgenic , Nerve Degeneration/metabolism , Nerve Degeneration/physiopathology , Neurogenesis/genetics , Neuronal Plasticity/genetics , Neurons/pathology , Pol1 Transcription Initiation Complex Proteins/genetics , RNA, Ribosomal/genetics , Stem Cells/metabolism , Stem Cells/pathology , Transcription, Genetic/genetics , Tumor Suppressor Protein p53/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...